Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: OM

Outset Medical, Inc.

Healthcare | Medical - Devices

Market prices for OM are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2025)$-5.37

Outset Medical, Inc. (NASDAQ: OM) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 07:45 UTC.

What Outset Medical, Inc. does

Outset is a medical technology company that develops the Tablo Hemodialysis System, an FDA-cleared machine designed to deliver dialysis across hospital, clinic, and home settings. Tablo integrates water purification and on-demand dialysate production in a compact console that requires only an electrical outlet and tap water, eliminating infrastructure constraints of traditional dialysis machines. The system features cloud connectivity for remote monitoring, data analytics, and automated record-keeping, along with a user-friendly touchscreen interface that reduces training time.

Summarized from Outset Medical, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (FY2025)$-5.37
Debt/equity1.01

Revenue, margins & earnings

FY2021: net loss $132M on revenue $103M$103MFY2021FY2022: net loss $163M on revenue $115M$115MFY2022FY2023: net loss $173M on revenue $130M$130MFY2023FY2024: net loss $128M on revenue $114M$114MFY2024FY2025: net loss $82M on revenue $119M$119MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-05
  • 2026-10-0510% OwnerPurchase228,334$806.0K
  • 2026-10-0510% OwnerPurchase16,575$64.2K
  • 2026-08-18General CounselSale-2,632$11.6K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Outset Medical, Inc. do?

Outset is a medical technology company that develops the Tablo Hemodialysis System, an FDA-cleared machine designed to deliver dialysis across hospital, clinic, and home settings.

When did OM last file with the SEC?

Outset Medical, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-17. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 07:45 UTC. This page is also available as JSON at /api/data?ticker=OM and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for OM and 5,000+ tickers.

Create a free account — keep OM
For your agent
GET /api/data?ticker=OM

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt